United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,104 out of 116,246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 125,419 | 110,338 |
| Total Cites | 7,125 | 9,323 |
| H-index | 44 | 52 |
| Hm-index | 16 | 19 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 20 | 20 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 1,150 | 1,343 |
| Number of Single+First+Last Authored Papers | 200 | 200 |
| Total Cites to Single+First+Last Authored Papers | 3,685 | 5,010 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,889 | 5,496 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.70 |
| Self-Citation Percentage |
23.58%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,326 out of 105,572 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 142,233 | 117,780 |
| Total Cites | 5,333 | 7,327 |
| H-index | 38 | 47 |
| Hm-index | 15 | 18 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 851 | 1,026 |
| Number of Single+First+Last Authored Papers | 208 | 208 |
| Total Cites to Single+First+Last Authored Papers | 3,009 | 4,232 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,628 | 4,170 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.76 |
| Self-Citation Percentage |
27.21%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,408 out of 101,860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 147,877 | 122,931 |
| Total Cites | 4,825 | 6,677 |
| H-index | 36 | 45 |
| Hm-index | 14 | 18 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 771 | 937 |
| Number of Single+First+Last Authored Papers | 203 | 203 |
| Total Cites to Single+First+Last Authored Papers | 2,774 | 3,935 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,327 | 3,842 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.74 |
| Self-Citation Percentage |
27.74%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,450 out of 84,246 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 151,280 | 125,268 |
| Total Cites | 4,093 | 5,787 |
| H-index | 34 | 42 |
| Hm-index | 14 | 17 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 658 | 809 |
| Number of Single+First+Last Authored Papers | 197 | 197 |
| Total Cites to Single+First+Last Authored Papers | 2,445 | 3,525 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2,796 | 3,278 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.77 |
| Self-Citation Percentage |
29.27%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.